Dudediligence.

Guardant Health, Inc

GHNASDAQ · Services-Medical Laboratories
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$191.5MSep ’24$201.8MDec ’24$203.5MMar ’25$232.1MJun ’25$265.2MSep ’25$281.3MDec ’25$301.7MMar ’26$335.0MJun ’26
Net income, by quarter
−$107.8MSep ’24−$111.0MDec ’24−$95.2MMar ’25−$99.9MJun ’25−$92.7MSep ’25−$128.5MDec ’25−$112.1MMar ’26−$120.1MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$373.7M$449.5M$563.9M$739.0M$982.0M
Gross profitnone on filenone on file$336.9M$449.2M$633.0M
Operating income−$411.0M−$544.4M−$564.7M−$443.6M−$437.2M
Net income−$384.8M−$654.6M−$479.4M−$436.4M−$416.3M
Operating cash flow−$209.0M−$309.5M−$325.0M−$239.9M−$184.8M
Free cash flow−$284.1M−$386.9M−$345.5M−$274.9M−$233.1M
Cash$492.2M$141.6M$1.13B$525.5M$378.2M
Debtnone on filenone on filenone on file$1.14B$1.50B
Shares outstanding101.8M102.6M121.6M124.0M130.6M